We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.11 | 0.10% | 106.40 | 106.76 | 105.15 | 106.71 | 3,735,176 | 00:24:06 |
From May 2019 to May 2024
Abbott Laboratories agreed to acquire the remaining stake in privately held Tendyne Holdings Inc. that it doesn't already own for $225 million upfront, resulting in a total transaction value of $250 million, plus potential milestone payments. "Abbott Labs Reaches Deals for Transcatheter Mitral-Valve Developers" published at 11:54 a.m. EDT incorrectly described the terms of the deal in the third paragraph.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
